{"id":88613,"date":"2018-02-02T10:18:00","date_gmt":"2018-02-02T10:18:00","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=c8e45d2e609596856f9e71d1b5937ffe"},"modified":"2018-02-02T10:18:00","modified_gmt":"2018-02-02T10:18:00","slug":"press-release-uk-and-china-sign-memorandum-of-understanding-on-medicine-and-device-regulation","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=88613","title":{"rendered":"Press release: UK and China sign Memorandum of Understanding on Medicine and Device Regulation"},"content":{"rendered":"
\n

Dr Ian Hudson, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) signed a memorandum of understanding (MoU) with the China Food and Drug Administration (CFDA) during a visit to China this week.<\/p>\n

This new signing expands on a previous MoU signed in 2014 which focussed on the exchange of safety information on medicines and medical devices to protect patients in the UK, China, and around the world.<\/p>\n

Dr Ian Hudson, Chief Executive Officer at MHRA said:<\/p>\n

\n

China is a world leader in the market for raw materials for the pharmaceutical industry and closer collaboration with MHRA will support the promotion of innovation, good practice, and protect UK patients.<\/p>\n<\/blockquote>\n

\n

We operate in a global environment and formalising our international relationships helps strengthen regulatory systems to protect public health worldwide.<\/p>\n<\/blockquote>\n

The MoU was signed in Beijing\u2019s Great Hall of the People with both Prime Minister Theresa May and China\u2019s Premier Li Keqiang present.<\/p>\n

\n
\n

Media enquiries<\/h3>\n
\n

\nNews centre<\/span>
\nMHRA
\n
\n151 Buckingham Palace Road
\n
\nVictoria<\/span>
\nLondon<\/span>
\nSW1W 9SZ<\/span>\n<\/p>\n

\n

\n Email<\/span>
\n newscentre@mhra.gov.uk<\/a>\n <\/p>\n

\n During office hours:<\/span>
\n 020 3080 7651 (08:30 – 17:00)\n <\/p>\n

\n Out of office hours:<\/span>
\n 07770 446 189 (17:00 – 08:30)\n <\/p>\n<\/p><\/div>\n

Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https:\/\/www.twitter.com\/mhrapress<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The agreement pledges new areas of cooperation such as an exchange of learning from the accelerated access review (AAR) and how to effectively regulate the trading of medicines online.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"_links":{"self":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/88613"}],"collection":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=88613"}],"version-history":[{"count":1,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/88613\/revisions"}],"predecessor-version":[{"id":88634,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/88613\/revisions\/88634"}],"wp:attachment":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=88613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=88613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=88613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}